Navigating Excellence: Unravelling Surgical Outcomes of Robotic Assisted Radical Nephrectomy

Original Article

Abstract

ABSTRACT

Objective: To assess the surgical outcomes of robotic-assisted radical nephrectomy, specifically focusing on early postoperative complications classified by the Clavien-Dindo classification system.

Study design : A Prospective Observational Study.

Duration and place of study. The Department of Urology, Sindh Institute of Urology and Transplantation (SIUT), Karachi, from October 2022 to September 2023

Material and Methods:  This prospective observational study was conducted at the Department of Urology, Sindh Institute of Urology and Transplantation (SIUT), Karachi, from October 2022 to September 2023. The study enrolled patients aged 30 to 70 years diagnosed with renal cell carcinoma and undergoing robotic-assisted radical nephrectomy. Informed consent was obtained from patients or their caretakers after explaining the risks and benefits of the study. The outcome variable, postoperative complications, was assessed. Data collected were entered and analysed using IBM SPSS v26.

Result: In this study we enrolled 82 patients with renal cell carcinoma undergoing robot assisted radical nephrectomy. Most of the patient in our study were male 67.07%. Post-operative complication was reported in 12 (14.6%). Among 12 patients with post operative complication, 33.3% were Clavien 1, 41.7% Clavien 2 and 16.7% were Clavien 3. However, no death was reported in our study cohort.

Conclusion: Our study findings indicates that robotic assisted radical nephrectomy is safe. Most postoperative complications are Clavien grade I or II, or can be managed conservatively.

Keywords: modified Clavien Dindo classification; renal cell carcinoma; radical nephrectomy; robotic surgery.